10.3390/biomedicines9050464 23 IzzoC.SecondulfoC.BilancioG.ViscoV.VirtuosoN.MigliarinoS.et al (2024)
It has shown potential as a neuroprotective agent against Aluminum-induced oxidative stress and shows promise to protect the brain against free radical damage
Rocha RM, Silva GV, de Albuquerque DC, Tura BR, Albanesi Filho FM
Proper storage and handling procedures are recommended to maintain product integrity, consistency, and analytical reliability throughout laboratory research environments
Conference Reports for NATAP The International Liver Congress EASL - European Association for the Study of the Liver June 21-24 2023 Back Pemvidutide Cuts NAFLD Liver Fat and Weight Through 24 Weeks EASL Congress 2023, June 21-24, Vienna Mark Mascolini Pemvidutide, a novel multiactive agent being developed for obesity and nonalcoholic steatohepatitis (NASH), promoted quick and large drops in liver fat content (LFC), weight, and liver enzymes after 12 and 24 weeks in a 94-person placebo-controlled trial [1]
They do work, but some people stop taking them due to side effects, which include nausea, vomiting, diarrhea, or constipation